Posted by Michael Wonder on 18 Mar 2022
Australian cancer patients to get improved access to clinical trials
17 March 2022 - Australian cancer patients will get improved access to local clinical trials through a new public-private partnership consortium, PrOSPECT, which today announced a funding agreement that is expected to enable a significant increase in local cancer clinical trial participation.
PrOSPECT – Precision Oncology Screening Platform Enabling Clinical Trials – is a collaboration of organisations that has partnered with the Federal and NSW Governments to expand access to comprehensive genomic profiling for cancer patients and enable clinical trial access.
